About 1 result found for searched term "BGB-16673" (0.146 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M40692 | BGB-16673 | PROTAC |
| BGB-16673 is an orally active chimeric degradation-activating compound targeting BTK that degrades wild-type BTK and a variety of mutant BTKs, and can be used in studies related to B-cell malignancies as well as non-Hodgkin's lymphoma. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
